- Home
- UTMD vs LYEL Comparison
UTMD vs LYEL Comparison
Compare UTMD & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UTMD
- LYEL
- Stock Information
- Founded
- UTMD 1978
- LYEL 2018
- Country
- UTMD United States
- LYEL United States
- Employees
- UTMD N/A
- LYEL N/A
- Industry
- UTMD Medical/Dental Instruments
- LYEL Biotechnology: Pharmaceutical Preparations
- Sector
- UTMD Health Care
- LYEL Health Care
- Exchange
- UTMD Nasdaq
- LYEL Nasdaq
- Market Cap
- UTMD 213.4M
- LYEL 203.9M
- IPO Year
- UTMD N/A
- LYEL 2021
- Fundamental
- Price
- UTMD $60.20
- LYEL $0.70
- Analyst Decision
- UTMD
- LYEL Sell
- Analyst Count
- UTMD 0
- LYEL 2
- Target Price
- UTMD N/A
- LYEL $1.00
- AVG Volume (30 Days)
- UTMD 26.0K
- LYEL 1.3M
- Earning Date
- UTMD 01-28-2025
- LYEL 03-03-2025
- Dividend Yield
- UTMD 2.03%
- LYEL N/A
- EPS Growth
- UTMD N/A
- LYEL N/A
- EPS
- UTMD 3.96
- LYEL N/A
- Revenue
- UTMD $40,903,000.00
- LYEL $63,000.00
- Revenue This Year
- UTMD N/A
- LYEL N/A
- Revenue Next Year
- UTMD N/A
- LYEL N/A
- P/E Ratio
- UTMD $15.20
- LYEL N/A
- Revenue Growth
- UTMD N/A
- LYEL N/A
- 52 Week Low
- UTMD $58.87
- LYEL $0.51
- 52 Week High
- UTMD $77.33
- LYEL $3.26
- Technical
- Relative Strength Index (RSI)
- UTMD 41.65
- LYEL 64.48
- Support Level
- UTMD $60.04
- LYEL $0.57
- Resistance Level
- UTMD $61.44
- LYEL $0.63
- Average True Range (ATR)
- UTMD 1.04
- LYEL 0.05
- MACD
- UTMD 0.03
- LYEL 0.02
- Stochastic Oscillator
- UTMD 36.44
- LYEL 87.86
About UTMD Utah Medical Products Inc.
Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals as well as outpatient clinics and physicians offices.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.